Targeting mechanisms of inter-organelle communication to promote healthy aging
细胞器间通讯的靶向机制促进健康衰老
基本信息
- 批准号:9886173
- 负责人:
- 金额:$ 24.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-30 至 2021-12-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseATF6 geneAddressAgeAge of OnsetAgingAnimalsAutomobile DrivingBehaviorBiologicalBiological ProcessCREB1 geneCaenorhabditis elegansCardiovascular DiseasesCellsCellular Metabolic ProcessCellular biologyClinicalCommunicationCoupledDataDefectDiabetes MellitusDietary InterventionDiseaseElderlyEndoplasmic ReticulumFertilityGene ExpressionGenesGeneticGenetic ModelsGoalsGrowthHealthHomeostasisImmunityIndividualInterventionKnowledgeLinkLongevityMalignant NeoplasmsMammalian CellMediatingMediator of activation proteinMembraneMetabolicMetabolismMicroscopyMitochondriaModelingMolecularMorbidity - disease rateMorphologyNeurodegenerative DisordersNuclearOnset of illnessOrganellesOsteoporosisOutputPathologyPathway interactionsPatientsPhasePhysiologyPlayProtein KinaseProteinsPublic HealthRegulationReproductionResolutionRisk FactorsRoleShapesSignal TransductionSiteStrokeSystemTestingTherapeuticTrainingTranscription CoactivatorTransgenic OrganismsTranslatingage relatedagedcomorbiditydesigndetection of nutrientdifferential expressionfunctional declinegene therapyhealthy agingimprovedin vivoin vivo monitoringinsightlipid metabolismmetabolomicsmitochondrial metabolismnovelpreventproteostasisresponsesensorside effecttargeted treatmenttherapeutic developmenttooltranscription factor
项目摘要
Project Summary/Abstract
Age-onset diseases including cancer, neurodegenerative disease, diabetes, cardiovascular disease, stroke,
and osteoporosis are generating a public health burden that is quickly becoming insurmountable. Exacerbating
this problem, co-morbidities are common among the elderly. The ideal therapeutic strategy to confront this
crisis is to target a unifying risk factor, but patient age is the only risk factor common to all these diseases.
Fortunately, it is increasingly clear that the biological processes of aging are malleable, thus the rate and
quality of aging may be improved. Genetic and nutritional interventions causing real or perceived energy-
depletion are robust, conserved mechanisms to promote healthier aging. Unfortunately these interventions,
e.g. activation of the molecular low-energy sensor AMPK, also carry clinically unacceptable side effects, such
as suppressed immunity and fertility. Translating these findings into therapeutics thus requires identification of
downstream mechanisms that are sufficient for healthier aging. Through a genetic model of longevity in C.
elegans via activation of AMPK, we demonstrated that the negative side-effects of energy-depletion can be
uncoupled from the positive effects on healthy aging. Using unbiased, systems-level approaches, we found
that the longevity-specific mechanism involves downstream regulation of mitochondrial dynamics and
metabolic functions, and we now demonstrate that regulation of mitochondrial dynamics is causal to AMPK
longevity. New data indicate that perturbing the unfolded protein response (UPR), which mediates homeostasis
of the endoplasmic reticulum (ER), interacts with the AMPK pathway to extend lifespan through a mechanism
that also requires mitochondrial remodeling. Given recent studies showing that the ER physically interacts with
mitochondria to regulate organelle morphology and metabolic signaling, these data suggest a new paradigm in
aging: ER/mitochondrial regulation of longevity occurs through an integrated metabolic mechanism. Physical
changes in mitochondrial networks are a hallmark of aging, but how organelle dynamics are mechanistically
involved in longevity is unknown. By genetically inactivating mediators of mitochondrial remodeling
(fission/fusion), Aim 1 will define how mitochondrial dynamics drive the changes in mitochondrial metabolism
associated with low-energy longevity. Through novel transgenics and training in high-resolution microscopy in
Aim 2, I will test the hypothesis that UPRER perturbations promote altered mitochondrial morphology and
signaling between organelles. Finally in the R00 phase, Aim 3 will build on the tools and insights developed in
Aims 1 and 2 to identify genetic mechanisms in C. elegans by which ER-mitochondrial inter-organelle
communication can be directly targeted to extend healthy lifespan and protect metabolic homeostasis. Taken
together, the goal of this proposal is to identify how evolutionarily conserved energy-sensing pathways
coordinately modulate inter-organelle signaling and metabolic function to promote longevity.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristopher Burkewitz其他文献
Kristopher Burkewitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristopher Burkewitz', 18)}}的其他基金
Targeting ER-mitochondrial calcium signaling to promote healthier aging
靶向 ER 线粒体钙信号传导以促进更健康的衰老
- 批准号:
10443143 - 财政年份:2022
- 资助金额:
$ 24.2万 - 项目类别:
Targeting ER-mitochondrial calcium signaling to promote healthier aging
靶向 ER 线粒体钙信号传导以促进更健康的衰老
- 批准号:
10643969 - 财政年份:2022
- 资助金额:
$ 24.2万 - 项目类别:
Targeting mechanisms of inter-organelle communication to promote healthy aging
细胞器间通讯的靶向机制促进健康衰老
- 批准号:
9242811 - 财政年份:2016
- 资助金额:
$ 24.2万 - 项目类别:
Targeting mechanisms of inter-organelle communication to promote healthy aging
细胞器间通讯的靶向机制促进健康衰老
- 批准号:
9812866 - 财政年份:2016
- 资助金额:
$ 24.2万 - 项目类别:
Targeting novel AMPK effectors in the regulation of healthy aging
靶向新型 AMPK 效应物调节健康衰老
- 批准号:
8803201 - 财政年份:2014
- 资助金额:
$ 24.2万 - 项目类别:
Targeting novel AMPK effectors in the regulation of healthy aging
靶向新型 AMPK 效应物调节健康衰老
- 批准号:
8527019 - 财政年份:2014
- 资助金额:
$ 24.2万 - 项目类别:
相似海外基金
Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
- 批准号:
2867610 - 财政年份:2023
- 资助金额:
$ 24.2万 - 项目类别:
Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
- 批准号:
BB/W009633/1 - 财政年份:2022
- 资助金额:
$ 24.2万 - 项目类别:
Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2021
- 资助金额:
$ 24.2万 - 项目类别:
Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
- 批准号:
459043 - 财政年份:2021
- 资助金额:
$ 24.2万 - 项目类别:
Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2020
- 资助金额:
$ 24.2万 - 项目类别:
Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10561642 - 财政年份:2019
- 资助金额:
$ 24.2万 - 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2019
- 资助金额:
$ 24.2万 - 项目类别:
Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
- 批准号:
2243045 - 财政年份:2019
- 资助金额:
$ 24.2万 - 项目类别:
Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10359032 - 财政年份:2019
- 资助金额:
$ 24.2万 - 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
- 批准号:
428988 - 财政年份:2019
- 资助金额:
$ 24.2万 - 项目类别:
Studentship Programs